ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Georgia » Rheumatology

Top Rheumatology Prescribers in Georgia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
WILLIAM TIDMORE M.D.

Rheumatology

21,362

$3.09M

1360
963 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

13%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 21%

$145
Average prescription price

Avg: $146

CHARLES GALEA M.D.

Rheumatology

13,317

$1.03M

770
461 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

18%
patients receiving schedule three controlled substances

Avg: 14%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 21%

$77
Average prescription price

Avg: $146

ERICK BOURNIGAL MD

Rheumatology

11,006

$1.19M

677
489 are 65+

2%
patients receiving schedule two controlled substances

Avg: 2%

4%
patients receiving schedule three controlled substances

Avg: 14%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 21%

$108
Average prescription price

Avg: $146

RICHARD BOSWELL MD

Rheumatology

10,011

$664K

702
545 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

4%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 21%

$66
Average prescription price

Avg: $146

THERESA LAWRENCE-FORD M.D.

Rheumatology

9,189

$1.65M

646
358 are 65+

9%
patients receiving schedule two controlled substances

Avg: 2%

29%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 21%

$180
Average prescription price

Avg: $146

MARTA BOGNAR M.D.

Rheumatology

8,638

$2.14M

777
569 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

17%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 21%

$248
Average prescription price

Avg: $146

JAMES MOSSELL D.O.

Rheumatology

8,534

$1.62M

634
332 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

29%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 21%

$190
Average prescription price

Avg: $146

NICHOLAS TILIAKOS M.D.

Rheumatology

7,831

$741K

600
439 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

19%
patients receiving schedule three controlled substances

Avg: 14%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 21%

$95
Average prescription price

Avg: $146

VICTOR MCMILLAN

Rheumatology

7,061

$664K

578
398 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

18%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 21%

$94
Average prescription price

Avg: $146

WILLIAM WILSON MD

Rheumatology

6,904

$1.24M

521
370 are 65+

8%
patients receiving schedule two controlled substances

Avg: 2%

15%
patients receiving schedule three controlled substances

Avg: 14%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 21%

$179
Average prescription price

Avg: $146

PHILIP MEADOW D.O. F.A.C.R.

Rheumatology

6,685

$859K

499
331 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

9%
patients receiving schedule three controlled substances

Avg: 14%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 21%

$128
Average prescription price

Avg: $146

GARY MYERSON MD

Rheumatology

6,296

$1.43M

589
477 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

9%
patients receiving schedule three controlled substances

Avg: 14%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 21%

$227
Average prescription price

Avg: $146

MOHAMMAD KAMRAN MD

Rheumatology

5,871

$939K

504
340 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

22%
patients receiving schedule three controlled substances

Avg: 14%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 21%

$160
Average prescription price

Avg: $146

ALAN GOTTLIEB MD

Rheumatology

5,825

$399K

414
315 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 21%

$68
Average prescription price

Avg: $146

KATHY LYNN M.D.

Rheumatology

5,698

$1.09M

413
289 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

21%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 21%

$191
Average prescription price

Avg: $146

JEFFREY PELLER MD

Rheumatology

5,673

$646K

458
330 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

24%
patients receiving schedule three controlled substances

Avg: 14%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 21%

$114
Average prescription price

Avg: $146

BRENT FLICKINGER MD

Rheumatology

5,668

$1.52M

552
365 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

13%
patients receiving schedule three controlled substances

Avg: 14%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 21%

$268
Average prescription price

Avg: $146

ALAN FISHMAN MD

Rheumatology

5,651

$403K

524
442 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 14%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 21%

$71
Average prescription price

Avg: $146

JEFFREY STARK MD

Rheumatology

5,527

$805K

618
446 are 65+

2%
patients receiving schedule two controlled substances

Avg: 2%

16%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 21%

$146
Average prescription price

Avg: $146

KELLY WESELMAN MD

Rheumatology

5,502

$556K

417
292 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

19%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 21%

$101
Average prescription price

Avg: $146

MICHAEL FRIEDMAN M.D.

Rheumatology

5,339

$758K

371
218 are 65+

8%
patients receiving schedule two controlled substances

Avg: 2%

15%
patients receiving schedule three controlled substances

Avg: 14%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 21%

$142
Average prescription price

Avg: $146

PALLAVI SHARMA M.D.

Rheumatology

5,326

$220K

493
279 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

12%
patients receiving schedule three controlled substances

Avg: 14%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

10%
prescriptions for brand name drugs

Avg: 21%

$41
Average prescription price

Avg: $146

ANNAPURNA BHAT MD

Rheumatology

5,254

$324K

416
231 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

16%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 21%

$62
Average prescription price

Avg: $146

KIMBERLEY WILSON M.D.

Rheumatology

5,067

$943K

309
188 are 65+

9%
patients receiving schedule two controlled substances

Avg: 2%

24%
patients receiving schedule three controlled substances

Avg: 14%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 21%

$186
Average prescription price

Avg: $146

MOHAMMED ABUBAKER MD

Rheumatology

5,065

$633K

455
347 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

20%
patients receiving schedule three controlled substances

Avg: 14%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 21%

$125
Average prescription price

Avg: $146

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank